1 |
Diener HC, Cunha L, Forbes C, et al. European stroke prevention study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke [J]. J Neurol Sci, 1996, 143(1-2): 1-13.
|
2 |
CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) [J]. Lancet, 1996, 348(9038): 1329-1339.
|
3 |
ESPRIT Study Group, Halkes PH, van Gijn J, et al. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial [J]. Lancet, 2006, 367(9523): 1665-1673.
|
4 |
Wang Y, Wang Y, Zhao X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack [J]. N Engl J Med, 2013, 369(1): 11-19.
|
5 |
Johnston SC, Easton JD, Farrant M, et al. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA [J]. N Engl J Med, 2018, 379(3): 215-225.
|
6 |
Wang Y, Johnston SC, Bath PM, et al. Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack [J]. BMJ, 2019, 364: l895-1898.
|
7 |
Kim JT, Park MS, Choi KH, et al. Comparative Effectiveness of Dual Antiplatelet Therapy With Aspirin and Clopidogrel Versus Aspirin Monotherapy in Acute, Nonminor Stroke: A Nationwide, Multicenter Registry-Based Study [J]. Stroke, 2019, 50(11): 3147-3155.
|
8 |
Adams HP BendixenJr, , Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment [J]. Stroke, 1993, 24(1): 35-41.
|
9 |
Jing J, Meng X, Zhao X, et al. Dual antiplatelet therapy in transient ischemic attack and minor stroke with different infarction patterns: subgroup analysis of the CHANCE randomized clinical trial [J]. JAMA Neurol, 2018, 75(6): 711-719.
|
10 |
Hong KS, Lee SH, Kim EG, et al. Recurrent ischemic lesions after acute atherothrombotic stroke: clopidogrel plus aspirin versus aspirin alone [J]. Stroke, 2016, 47(9): 2323-2330.
|
11 |
Kim D, Park JM, Kang K, et al. Dual Versus mono antiplatelet therapy in large atherosclerotic stroke [J]. Stroke, 2019, 50(5): 1184-1192.
|
12 |
SPS3 Investigators, Benavente OR, Hart RG, et al. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke [J]. N Engl J Med, 2012, 367(9): 817-825.
|
13 |
中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2014 [J]. 中华神经科杂志, 2015, 48(4): 258-273.
|
14 |
Investigators ACTIVE, Connolly SJ, Pogue J, et al. Effect of clopidogrel added to aspirin in patients with atrial fibrillation [J]. N Engl J Med, 2009, 360(20): 2066-2078.
|
15 |
Diener HC, Bogousslavsky J, Brass LM, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial [J]. Lancet, 2004, 364(9431): 331-337.
|
16 |
Pan Y, Chen W, Xu Y, et al. Genetic polymorphisms and clopidogrel efficacy for acute ischemic stroke or transient ischemic attack: a systematic review and meta-analysis [J]. Circulation, 2017, 135(1): 21-33.
|
17 |
Johnston SC, Amarenco P, Denison H, Evans SR,et al. The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design [J]. Int J Stroke, 2019, 14(7): 745-751.
|
18 |
Frankish H. News from the International Stroke Conference, 2019 [J]. Lancet Neurol, 2019, 18(4): 337.
|
19 |
Bath PM, Woodhause LJ, Appleton JP, et al. Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus cloplidogrel alone or aspirin and dipyridanmole in patients with acute cerebral ischaemia (TARDIS): a radomised, open-label, phase 3 superiority trial [J]. Lancet, 2018, 391(10123): 850-859.
|
20 |
Hilkens NA, Algra A, Diener HC, et al. Predicting major bleeding in patients with noncardioembolic stroke on antiplatelets: S2TOP-BLEED [J]. Neurology, 2017, 89(9): 936-943.
|
21 |
Ding L, Peng B. Efficacy and safety of dual antiplatelet therapy in the elderly for stroke prevention: a systematic review and meta-analysis [J]. Eur J Neurol, 2018, 25(10): 1276-1284.
|